Maximize ROI by 11x with In-House NGS
GMP-Validated. NGS Solutions. In-House.
Do The Math: The Unrealized ROI In Lab Automation
Jana Hersch November 14, 2025
NGS in GMP Manufacturing: Reducing Risk, Increasing Return
Christoph Bredack November 6, 2025
NGS-Based Assays for CGT Development
October 23, 2025
Enhancing Gene Therapy Assets with GMP-Ready NGS Assays
Industry Experiences in Bringing NGS-Based Workflows In-House
Alison Waterfield September 29, 2025
Rapid Contamination Identification with Nanopore Sequencing
Automating Adventitious Agent Detection for GMP and Lot Release
Genedata Biopharma Platform: Digitalizing R&D
NGS Analyses. GxP-Ready. Unlimited.
Genedata Selector
NGS-Powered CMC Strategies
CHO Cell Line Characterization with NGS
Valentina Armiento September 11, 2025
GMP-Ready NGS Platform for mRNA Therapeutics
Democratizing NGS Analysis for Cell Line Development
Biotherapeutics Development with NGS Assays In-House
Genedata Selector 2025 Highlights Video
Next-Gen Cell Line Characterization
Valentina Armiento July 23, 2025
Industry Experts: Best Practices for Validated Biosafety Workflows
Enhancing ROI with Long-Read Sequencing
Raed Hmadi June 16, 2025
NGS-Based Vector Integrity Confirmation for Gene Therapy Products
Genedata June 13, 2025
Journey to Validated NGS In-House
Accelerating Biopharmaceutical and Vaccine Research, Discovery, and Development
NGS for CMC of Gene and Cell Therapy Products
Long-Read NGS for QC in CGTs Manufacturing
Validation-Ready NGS Workflows for Biosafety Testing
Advanced NGS for CLD in CGT Development
Valentina Armiento April 21, 2025
Do's and Don'ts of CSV for In-House NGS-Based Biosafety Assays
Accessible and Limitless NGS Analyses
GMP-Compliant NGS for Biotherapeutics Development
Advancing Cell Therapy R&D With Automated NGS Data Analysis
NGS-Based Solutions for Cell Line Development
Next Generation Trait Development and Crop Protection
End-to-End Digital Solution for NGS Labs
Genedata Selector: GMP Compliance for Safe Gene Therapy Development
Industry Insights: GMP-Compliant NGS-Based Workflows
Raed Hmadi October 15, 2024
Comprehensive Antibody Discovery Screening with NGS
Unlocking Insights from Long Read-Sequencing for Product QC
Automating Gene Therapy Long-Read Based QC Assays
Safety of Human Cell Products: The Value of NGS
